Skip to content
Inciteful Med

Multiple System Atrophy (MSA)

Last updated:

Multiple System Atrophy (MSA) is a rare, progressive neurological disorder that impacts involuntary functions like blood pressure and motor control. Early symptoms often resemble Parkinson's disease. Comprehensive management requires a specialized care team and strong psychological support.

Key Takeaways

  • • Multiple System Atrophy is a rapidly progressive neurological disorder affecting both involuntary autonomic functions and voluntary motor control.
  • • Early symptoms of MSA frequently mimic Parkinson's disease, making an initial accurate diagnosis challenging.
  • • The condition is divided into specific subtypes, primarily MSA-P and MSA-C, which guide monitoring and symptom management.
  • • Building a multidisciplinary care team is essential for managing the complex physical and emotional challenges of the disease.
  • • Connecting with patient advocacy groups like the MSA Coalition provides vital resources and community support.

Multiple System Atrophy (MSA) is a rare, rapidly progressive neurological disorder. It affects the body’s involuntary (autonomic) functions, including blood pressure, breathing, bladder function, and motor control. Because early symptoms often mimic Parkinson’s disease, reaching an accurate diagnosis can be a long and difficult journey.

This guide is designed to help you and your caregivers understand the biology of MSA, recognize its unique symptoms, build a specialized care team, and navigate the challenges ahead. Receiving a diagnosis of a rapidly progressing, incurable disorder is deeply distressing. It is important to remember that you are not alone. Seeking psychological support and connecting with patient advocacy groups, such as the MSA Coalition, can provide vital community support and resources.

Frequently Asked Questions

What is Multiple System Atrophy (MSA)?
Multiple System Atrophy (MSA) is a rare, rapidly progressive neurological disorder. It affects your body's involuntary autonomic functions, such as blood pressure, breathing, and bladder control, as well as your voluntary motor movements.
Why is MSA often misdiagnosed initially?
In its early stages, MSA frequently mimics the symptoms of Parkinson's disease. Because the initial warning signs are so similar, reaching a definitive and accurate diagnosis can be a long and challenging process.
What are the different types of MSA?
The condition is generally categorized into two main subtypes: MSA-P and MSA-C. These classifications are based on your most prominent symptoms and specific findings on your brain scans.
Where can I find support after an MSA diagnosis?
Connecting with patient advocacy groups like the MSA Coalition is highly recommended. Additionally, seeking out a mental health professional who specializes in neurodegenerative diseases can provide vital emotional support for both you and your caregivers.

Questions for Your Doctor

  • • What support groups or patient advocacy organizations, such as the MSA Coalition, do you recommend I connect with?
  • • Can you refer me to a mental health professional who has experience working with patients facing neurodegenerative diseases?
  • • What is the immediate next step in building my multidisciplinary care team?

Questions for You

  • • Who do I want to have with me at my medical appointments to help listen and take notes?
  • • What are my most pressing physical or emotional concerns right now?
  • • Am I open to seeking counseling or joining a support group to help manage the emotional impact of this diagnosis?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

This page provides an educational overview of Multiple System Atrophy (MSA). Because MSA is a complex and progressive condition, always consult your neurologist and multidisciplinary care team for personalized medical advice and symptom management.

Stay up to date

Get notified when new research about Multiple system atrophy is published.

No spam. Unsubscribe anytime.